Abstract:Cervical cancer is the fourth leading cause of death in women, especially in developing countries. Specific and economic methodologies for HPV typing are crucial in cancer diagnosis and further disease control. However, routine assays based on real-time polymerase chain reaction (qPCR) or DNA-chip hybridization are either incapable of offering detailed subtype information or involve tedious open-tube operations with the risk of cross-contamination from PCR amplicons. Herein, we proposed a multiplex visualized closed-tube PCR (Multi-Vision) for HPV typing. Using gold nanoparticle probes (AuNPs) as a color change indicator combined with a Hamming distance 2 coding scheme, 13 high-risk HPVs and two subtypes associated with high-incidence benign lesions were successfully typed by performing six closed-tube PCRs. The assay demonstrates high specificity with no cross-reaction among different subtypes under several artificial sample concentrations (from 100 to 103 copies per reaction) and enables highly sensitive detection of as low as 0.5 copies/μL. Further, 105 clinical samples were successfully analyzed using our method with a high concordance rate of 99.05% (104/105) compared to a HPV typing kit. The inconsistent sample was confirmed by sequencing to be consistent with the typing results determined by our method, indicating that Multi-Vision could be a useful tool for HPV detection, especially in resource-limited regions.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.1c00035?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.1c00035</a>.Sequence information of PCR primers and downstream probes of 15 HPV subtypes; probe sequence information for hybridization-induced assembly of AuNPs; positive typing interpretation of 15 HPV subtypes; typing scheme of 15 HPV subtypes with seven tubes; characterization results of oligonucleotide probe-modified AuNPs with TEM images and UV–visible spectra; state changes of tube solution with AuNP aggregation for HPV73 detection with visualized typing results and UV–visible spectra; agarose gel electrophoresis (2%) of 15 HPV subtype multiple PCR products; optimization results of reaction conditions including overall DP concentrations, FEN1 amounts, and invader reaction time; optimization results of Dp-51, Dp-11, and Dp-16 concentrations in corresponding tubes under different template amounts; visualized results of sensitivity evaluation of 15 HPV subtypes along with UV–visible spectra in the range of 300–750 nm; typing analysis results of sample no. 1805112-4 (S69) by PCR-RDB HPV detection and the Multi-Vision assay and its verification by agarose gel electrophoresis (2%); and viability of clinical sample detection by the Multi-Vision HPV genotyping assay and the clinical PCR-RDB HPV detection kit (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.1c00035/suppl_file/ac1c00035_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

HPV genotyping in clinical samples using long‐read single‐molecule real‐time sequencing

Clinical Significance of Genotyping for Human Papillomavirus (HPV) 16 18/45 Combined with Cytology in Cervical Exfoliated Cells in HPV Oncogenic Mrna-Positive Women

Genome sequencing accuracy by RCA-seq versus long PCR template cloning and sequencing in identification of human papillomavirus type 58

Genotyping of Human Papillomavirus in Cervical Lesions by L1 Consensus PCR and the Luminex Xmap System.

Simultaneous Detection And Differentiation Of Human Papillomavirus Genotypes 6, 11, 16 And 18 By Allglo Quadruplex Quantitative Pcr

A multiplex RPA-CRISPR/Cas12a-based POCT technique and its application in human papillomavirus (HPV) typing assay

Development of a Multiplex PCR Method for Detecting and Typing Human Papillomaviruses in Verrucae Vulgaris

Diagnostic accuracy of extended HPV DNA genotyping and its application for risk-based cervical cancer screening strategy

Multiplex Visualized Closed-Tube PCR with Hamming Distance 2 Code for 15 HPV Subtype Typing

Development and validation of real-time recombinase polymerase amplification-based assays for detecting HPV16 and HPV18 DNA

Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.

Development and Validation of a New HPV Genotyping Assay Based on Next Generation Sequencing

High-throughput and Automatic Typing Via Human Papillomavirus Identification Map for Cervical Cancer Screening and Prognosis.

Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection

Analytical evaluation of the automated genotyping system (GenPlex) compared to a traditional real‐time PCR assay for the detection of high‐risk human papillomaviruses

Head-to-head comparison of genotyping of human papillomavirus by real-time multiplex PCR assay using type-specific primers and SPF10-PCR-based line probe assay

Multiplatform comparison of multiplexed bead arrays using HPV genotyping as a test case

Development, Validation, and Implementation of an Augmented Multiwell, Multitarget Quantitative PCR for the Analysis of Human Papillomavirus Genotyping through Software Automation, Data Science, and Artificial Intelligence

A Comparative Study of Three Different Nucleic Acid Amplification Techniques Combined with Microchip Electrophoresis for Hpv16 E6/E7 Mrna Detection

Whole Genome Assembly of Human Papillomavirus by Nanopore Long-Read Sequencing

A New Pcr-Based Mass Spectrometry System For High-Risk Hpv, Part Ii Clinical Trial